AIDS Research and Treatment in sooty mangabeys and rhesus macaques,” Journal of Virol- ogy, vol. 72, no. 12, pp. 9597–9611, 1998. [77] T. Whittall, B. Peters, D. Rahman, C. I. Kingsley, R. Vaughan, and T. Lehner, “Immunogenic and tolerogenic signatures in human immunodeﬁciency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control,” Clinical & Experimental Immunology, vol. 166, no. 2, pp. 208–217, 2011. [78] V. Vieillard, H. Fausther-Bovendo, A. Samri, and P. Debre, “Speciﬁc phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers,” Journal of Acquired Immune Deﬁciency Syndromes, vol. 53, no. 5, pp. 564–573, 2010. [79] F. Heil, H. Hemmi, H. Hochrein et al., “Species-speciﬁc rec- ognition of single-stranded RNA via Till-like receptor 7 and 8,” Science, vol. 303, no. 5663, pp. 1526–1529, 2004. [80] J. J. Chang and M. Altfeld, “TLR-mediated immune activa- tion in HIV,” Blood, vol. 113, no. 2, pp. 269–270, 2009. [81] A. Meier, J. J. Chang, E. S. Chan et al., “Sex diﬀerences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1,” Nature Medicine, vol. 15, no. 8, pp. 955–959, 2009. [82] G. Stary, I. Klein, S. Kohlhofer et al., “Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients,” Blood, vol. 114, no. 18, pp. 3854– 3863, 2009. [83] D. Y. Oh, K. Baumann, O. Hamouda et al., “A frequent func- tional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression,” AIDS, vol. 23, no. 3, pp. 297–307, 2009. [84] J. Chang, R. J. Lindsay, S. Kulkarni, J. D. Lifson, M. Carrington, and M. Altfeld, “Polymorphisms in interferon regulatory factor 7 reduce interferon-α responses of plasma- cytoid dendritic cells to HIV-1,” AIDS, vol. 25, no. 5, pp. 715– 717, 2011. [85] K. Machmach, M. Leal, C. Gras et al., “Plasmacytoid den- dritic cells reduce HIV production in elite controllers,” Jour- nal of Virology, vol. 86, no. 8, pp. 4245–4252, 2012. [86] J. N. Mandl, A. P. Barry, T. H. Vanderford et al., “Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infec- tions,” Nature Medicine, vol. 14, no. 10, pp. 1077–1087, 2008. [87] L. Meyaard, S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. M. Keet, and F. Miedema, “Programmed death of T cells in HIV- 1 infection,” Science, vol. 257, no. 5067, pp. 217–219, 1992. [88] B. E. Palmer, N. Blyveis, A. P. Fontenot, and C. C. Wilson, “Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction,” Journal of Immunology, vol. 175, no. 12, pp. 8415–8423, 2005. [89] C. Franceschi, M. G. Franceschini, A. Boschini et al., “Phe- notypic characteristics and tendency to apoptosis of periph- eral blood mononuclear cells from HIV+ long term non progressors,” Cell Death and Diﬀerentiation, vol. 4, no. 8, pp. 815–823, 1997. [90] M. Schweneker, D. Favre, J. N. Martin, S. G. Deeks, and J. M. McCune, “HIV-induced changes in T cell signaling pathways,” Journal of Immunology, vol. 180, no. 10, pp. 6490– 6500, 2008. [91] S. Zanussi, C. Simonelli, M. D’Andrea et al., “CD8+ lympho- cyte phenotype and cytokine production in long-term non- progressor and in progressor patients with HIV-1 infection,” Clinical and Experimental Immunology, vol. 105, no. 2, pp. 220–224, 1996. 11 [92] M. D. Hazenberg, D. Hamann, H. Schuitemaker, and F. Miedema, “T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock,” Nature Immunology, vol. 1, no. 4, pp. 285–289, 2000. [93] S. Read, S. Mauze, C. Asseman, A. Bean, R. Coﬀman, and F. Powrie, “CD38+ CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activities in vitro,” European Journal of Immunology, vol. 28, no. 11, pp. 3435–3447, 1998. [94] C. Baecher-Allan, J. A. Brown, G. J. Freeman, and D. A. Haﬂer, “CD4+CD25high regulatory cells in human peripheral blood,” Journal of Immunology, vol. 167, no. 3, pp. 1245– 1253, 2001. [95] A. Yoshizawa, A. Ito, Y. Li et al., “The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation,” Transplantation Proceedings, vol. 37, no. 1, pp. 37–39, 2005. [96] S. Sakaguchi, “Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self,” Nature Immunology, vol. 6, no. 4, pp. 345–352, 2005. [97] S. S. Bernardes, I. K. Borges, J. E. Lima et al., “Involvement of regulatory T cells in HIV immunopathogenesis,” Current HIV Research, vol. 8, no. 4, pp. 340–346, 2010. [98] J. C. Gaardbo, S. D. Nielsen, S. J. Vedel et al., “Regulatory T cells in human immunodeﬁciency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy,” Clinical and Experimental Immunology, vol. 154, no. 1, pp. 80–86, 2008. [99] L. Weiss, V. Donkova-Petrini, L. Caccavelli, M. Balbo, C. Carbonneil, and Y. Levy, “Human immunodeﬁciency virus- driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-speciﬁc CD4 T-cell responses in HIV-infected patients,” Blood, vol. 104, no. 10, pp. 3249–3256, 2004. [100] A. Lim, D. Tan, P. Price et al., “Proportions of circulating T cells with a regulatory cell phenotype increase with HIV- associated immune activation and remain high on antiretro- viral therapy,” AIDS, vol. 21, no. 12, pp. 1525–1534, 2007. [101] B. Kanwar, D. Favre, and J. M. McCune, “Th17 and regu- latory T cells: implications for AIDS pathogenesis,” Current Opinion in HIV and AIDS, vol. 5, no. 2, pp. 151–157, 2010. [102] L. Brandt, T. Benﬁeld, H. Mens et al., “Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllers,” Journal of Acquired Immune Deﬁciency Syndromes, vol. 57, no. 2, pp. 101–108, 2011. [103] Y. Jiao, J. Fu, S. Xing et al., “The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long- term non-progressors,” Immunology, vol. 128, supplement 1, pp. e366–e375, 2009. [104] L. Li, Y. Liu, Z. Bao et al., “Analysis of CD4+CD25+Foxp3+ regulatory T cells in HIV-exposed seronegative persons and HIV-infected persons with diﬀerent disease progressions,” Viral Immunology, vol. 24, no. 1, pp. 57–60, 2011. [105] A. J. Chase, H. C. Yang, H. Zhang, J. N. Blankson, and R. F. Siliciano, “Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeﬁciency virus type 1- infected elite suppressors correlates with low CD4+ T-cell activation,” Journal of Virology, vol. 82, no. 17, pp. 8307– 8315, 2008. [106] P. W. Hunt, A. L. Landay, E. Sinclair et al., “A low T regula- tory cell response may contribute to both viral control and